Blue Horseshoe Stocks: Perfectly-Timed Bottom Plays & More

Allakos, Inc. ALLK –  Recap

We began tracking ALLK on Monday morning, and formulated some options ideas ($45-60) which worked for us in Monday’s session, bringing in some nice gain opportunities. Then yesterday rolled around and we shared the huge news reported by the company in our premarket report along with the gains that our options ideas made.

The news on ALLK proved to be very influential on the activity of the stock, pushing it even further than Monday’s big surge had taken it. From the low that morning of 60.34, ALLK has run all the way up to a new high yesterday at 85.40, which marked a two-day upswing of 42%

While the lower end of our tracked options range was too deep in the money to see any real progress, the $60 Calls remained in play, and hit a high of 23.82. From our observed low of 6.75 on Monday, those contracts rose by a whopping 253%
_____

We also signaled interest in the Innovative Industrial Properties, Inc. IIPR 08/16 $100-105 Calls 
yesterday, and those got off to a modest, yet promising start. The $100’s traded in a range from 6.50-7.90 for a rise of 22%, while the $105’s ran 23% from 4.50-5.90. We’ll continue to monitor these ideas into their expiration next week.
_____

Fresh Ideas: 
CVS Weekly $55.50-57 Calls
SPY Weekly $286-285 Puts



Durect Corp DRRX


We also want to highlight the incredible performance that DRRX has had this summer to finish things up this morning. We tagged the stock for observation on May 28th, at which time we observed a low of .50, and it turned out to be a great nbottom call, as it hasn’t looked back since.

Slow and steady growth over the past two months has brought DRRX to a new high of 1.44 this week. That represents an overall increase of 188% in the time we’ve been observing this play.


Extended Watchist: 
MRNA, EVH, CPE, ENDP, AVGR, TVIX, APVO, ONVO

Blue Horseshoe Stocks: Huge SPY Gains, AMPG New Highs

Amplitech Group, Inc. AMPG – Update

We were all over AMPG once again last week, as we have been since the beginning of April when we initiated coverage on the stock. The move on Friday followed the news that the company virtually doubled their yearly expected sales via acquisition of a long-established, privately-held company.

AMPG made a 15% intraday push to a new high of .063 which works out to an overall increase of 47% over the .043 low we observed on the day of our initial report on the company (04/01/19). It also came with the biggest single-session volume recorded over these past six weeks.

Friday’s gains pushed AMPG‘s market cap above the $3M mark, although we would argue that even at that price, the stock is still grossly undervalued at present. Especially when one considers that it’s notably less than the combined expected annual sales of AMPG and the pending acquisition target, which you can read about in the link to the news above, or in the 8-K filed this morning.

We remain excited for the future potential of this company, and its stock. Stay tuned for future updates and be sure to commence your own due diligence, starting at AmpliTechInc.com.


SPDR S&P500 ETF (SPY) – Recap

Along with our coverage of AMPG on Friday morning, we also included a fresh options idea for the SPY that was incredibly successful, and reinforcing the strength of our commitment to producing the very best ideas that we can.

We cited the SPY Weekly $284-285.50 Calls, and with the help of a strong second half of the day for the markets as a whole, yielded the following enormous gain opportunities:

$284 Calls – Range: .59-4.82 – Max Gain: 717%
$284.50 Calls – Range: .43-4.20  – Max Gain: 877%
$285 Calls – Range: .30-3.84 – Max Gain: 1180%
$285.50 Calls – Range: .21-3.29  – Max Gain: 1467%


Extended Watchlist:
TVIX, AXNX, IZEA, MOSY, SQQQ, CPRX

Blue Horseshoe Stocks: Epic BPTH Run

Bio-Path Holdings, Inc. BPTH

We’ve been talking about BPTH all week, after the stock we tagged as a bottom watch play in our morning report on January 23rd had come up from our observed low of 2.65 to nearly the $15-mark. It was an incredible gain indeed, but nothing could have prepared us for what was to come.

Yesterday, following the company’s clinical update on its Phase 2 acute myeloid leukemia drug, prexigebersen, we saw an explosion on the chart that can only be described as the rarest of the rare. BPTH shot up from a daily low of 17.01 to an astounding high of 73.52! That worked out to an intraday swing of 332% As measured from the low following our January alert on the stock, BPTH posted an increase of  2,674% in a matter of just five weeks.

The stock pulled back to the high $30’s following that epic run, so it would appear that the above-mentioned figure will be the final maximum gain on our idea. While this has a chance to go down as our best stock call of the year, the chances that we score bigger gains on options ideas are extremely high. So we encourage any non-subscribers reading this to sign up as soon as possible!


Fresh Options Ideas

Speaking of options, which have also brought us several multi-bag gain opportunities this week, we’ll go ahead and close out this incredibly successful week with a pair of ideas that seem to be good bets here in the premarket. Horrid payroll numbers are contributing to what appears to be an impending bearish day for the markets.

SPY Weekly $274.50-273 Puts*
BIG 03/15 $35-37.50 Calls

*Never trade weekly options on a Friday unless you are an expert level trader with access to disposable funds.


Extended Watchlist:
DSKE, TRIL, SAEX, SEEL, PULM, TROV, TVIX, XXII